・Research and development of technologies related to regenerative medicine ・Manufacture, sale and import/export of goods related to regenerative medicine ・Acquisition, possession, licensing, transfer and management of intellectual property such as industrial property rights and copyrights
A startup from UCF’s School of Medicine applying exosome technology to regenerative medicine, drug delivery, non-invasive diagnostics, and medical device development. It aims to improve quality of life through innovative healthcare solutions for intractable diseases.
Elcyo develops innovative autofocal glasses that automatically adjust focus with proprietary lens technology. Leveraging Fresnel Liquid Crystal Lens Technology, Elcyo has made it possible to create glasses that maintain focus at any distance, addressing a wide range of vision challenges across healthcare, entertainment, and beyond.
Solaris Bio revolutionizes regenerative medicine by integrating proprietary Animal-Origin-Free (AOF) formulation designs with advanced cell protection expertise. Centered on our "Organic Solvent-Free Cryopreservation Solution," which boasts the highest safety standards, we offer comprehensive cell manufacturing solutions, including world-class growth media. Leveraging innovative R&D and quality verified by the Certificate of Material Eligibility, we simultaneously enhance cell product efficacy and reduce costs, powerfully accelerating the social implementation of next-generation healthcare.
Focusing on microvascular disorders throughout the body, we have developed the world's first “vascular endothelial stem cells” as a cell-based therapeutic agent, providing a novel vascular regeneration treatment to reduce the risk of heart disease and dementia.